Free Download here —> http://ow.ly/Ez9N
Timely analysis of global bioscience private and public capital investment activity made available by OnBioVC. In 3Q09, over $1,663M has flowed into early-stage biopharma, diagnostic and device companies and over $4,806M year-to-date.